Topics

Pacific EcoSolutions, Inc Company Profile

14:25 EST 5th December 2019 | BioPortfolio

Pacific EcoSolutions, Inc. (PEcoS), a wholly owned subsidiary of Nuvotec USA, Inc. (www.nuvotecusa.com), is a comprehensive nuclear waste processing facility located in Richland, Washington. The 45-acre PEcoS waste processing complex is comprised of a Low Level Waste (LLW) Facility and a Mixed Low Level Waste (MLLW) Facility. PEcoS was formed in September 2003 as a result of local investors acquiring the assets of the former Allied Technology Group, Inc.’s Richland-based processing operations.The LLW Facility encompasses approximately 70,000 square feet and can treat more than eight million pounds of solid, liquid, and wet waste annually. This facility has a radioactive materials license and uses both thermal and non-thermal technologies to treat LLW.
The MLLW Facility encompasses approximately 80,000 square feet and has operations permitted for the treatment of highly regulated wastes at a capacity of approximately 21 million pounds of waste annually. This facility has a radioactive materials license, as well as a RCRA Permit with TSCA approval, and is the only integrated mixed treatment facility in the United States.
The combination of these radioactive material licenses and the RCRA Permit allows PEcoS the significant advantage of treating both LLW and MLLW within a single waste processing complex thereby making PEcoS the most comprehensive waste treatment facility in the United States.
The recent merger of PEcoS with Nuvotec, Inc. (a Richland-based technology commercialization and technical services company) to form Nuvotec USA, Inc. will benefit PEcoS as the merger facilitates access to Nuvotec, Inc.’s nuclear-related technical expertise to help PEcoS expand its waste processing capabilities. PEcoS’ waste treatment capabilities are already being augmented by the deployment of Nuvotec’s plasma-based waste treatment system to treat MLLW.

Location

723 The Parkway
Richland
Washington
99352
United States of America

Contact

Phone: (509) 943-5319
Fax: (509) 943-5528
Email: bob.denne@pacificecosolutions.com


News Articles [155 Associated News Articles listed on BioPortfolio]

Viridium Pacific Group Ltd. Announces Name Change to Experion Holdings Ltd.

VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / Viridium Pacific Group Ltd. (the 'Company") (TSX-V: VIR ) is pleased to announce that the Company has changed its name from "Viridium Pacific Group Ltd....

Interactions between Kuroshio Extension and Central Tropical Pacific lead to preferred decadal-timescale oscillations in Pacific climate

Eisai Selected for Membership in Dow Jones Sustainability Asia Pacific Index 2019

TOKYO, Sept 18, 2019 - (JCN Newswire) - Eisai Co., Ltd. has been selected for a membership in the Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), the Asia Pacific version of the Do...

Battlefield 5 hits the Pacific later in 2019 – Eurogamer.net

Battlefield 5 hits the Pacific later in 2019 Eurogamer.netBattlefield 5: Chapter 5 Development Teaser Trailer - E3 2019 IGNBattlefield 5 getting new maps, new Pacific theater of war later this year ...

Viridium Pacific Group Ltd.: Viridium Pacific Group Announces Results Of Annual General Meeting

VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and specia...

Addressing Questions Left Unanswered by PACIFIC in Stage III NSCLC

Lyudmila A. Bazhenova, MD, discusses the phase III PACIFIC trial and clinical scenarios that warrant further investigation in the field of stage III non–small cell lung cancer.

PACIFIC Immunotherapy Data Open Research Opportunities in Stage III NSCLC

Drew Moghanaki, MD, MPH, discusses the impact of the PACIFIC trial and future research in stage III non–small cell lung cancer.

PACIFIC Trial Paves Way for More Immunotherapy Advances in Stage III NSCLC

Anna Chalmers, MD, discusses the PACIFIC trial and how its impact continues to change the treatment paradigm in stage III non-small cell lung cancer. 

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [pacific island medical, inc.]

Oxygen, USP

Polymyxin b sulfate and trimethoprim sulfate [h.j. harkins company, inc.]

POLYMYXIN B SULFATE and TRIMETHOPRIM

Prednisolone acetate [preferred pharmaceuticals, inc.]

PREDNISOLONE ACETATEophthalmic suspension, USP 1.0%

Dapsone [pacific pharma, inc.]

These highlights do not include all the information needed to use dapsone gel, 5% safely and effectively. See full prescribing information for dapsone gel, 5%.     Dapsone gel, 5%, for topical use ...

Gentamicin sulfate [rebel distributors corp]

GENTAMICIN SULFATEOphthalmic Solution, USP 0.3%

PubMed Articles [286 Associated PubMed Articles listed on BioPortfolio]

Speech in Catatonia-A Terra Incognita!

Urdu translation of the Ottawa Self-injury Inventory version 3.1.

Schizophrenia neuro exam: The oft-times-overlooked motor symptom domain.

Best Practices for Community-Engaged Research with Pacific Islander Communities in the US and USAPI: A Scoping Review.

This scoping review identifies the best practices of community-based participatory research with Pacific Islanders in the United States and United States Affiliated Pacific Islands. Eighty-four articl...

Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients.

Recently, based on results of the PACIFIC trial, durvalumab after chemoradiotherapy (CRT) became the standard therapy for unresectable stage III non-small cell lung cancer (NSCLC). However, in the PAC...

Clinical Trials [75 Associated Clinical Trials listed on BioPortfolio]

Remission in Rheumatoid Arthritis in the Asian-Pacific Region

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in ...

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

The purpose of this study is to understand the utilization patterns of doripenem in Asia Pacific, including the profile of the patients treated with carbapenems.

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

Since the infectious aetiology of AECOPD has been suggested to vary according to geographical region, the primary purpose of this study (which will be conducted in several countries in Asi...

Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific

This study will determine the prevalence of HIV-related neurological disorders in the countries of the Asia-Pacific Region.

Evaluation of Atuna Racemosa Toxicity

For thousands of years people in the South Pacific have used Atuna racemosa extract as a topical anti-inflammatory. We, the researchers at the Mayo Clinic, have shown this extract to also...

Companies [282 Associated Companies listed on BioPortfolio]

Pacific EcoSolutions, Inc

Pacific EcoSolutions, Inc. (PEcoS), a wholly owned subsidiary of Nuvotec USA, Inc. (www.nuvotecusa.com), is a comprehensive nuclear waste processing facility located in Richland, Washington. The 45-ac...

Pacific Life Foundation

The Pacific Life Foundation was established by Pacific Life Insurance Company in 1984 as a way to provide a permanent charitable endowment to improve the communities in which empl...

Pacific Prime

Established in 2000 in Hong Kong, Pacific Prime has grown from its humble beginnings to becoming the largest health insurance and employee benefits brokerage in Asia. To learn mor...

Pacific Edge Dental Laboratories

Pacific Edge Dental Laboratories was established on the foundation of service excellence, continuing technical education and quality assurance. Our laboratory is located just a few minutes south of ...

Pacific Life Insurance Company

Offering insurance since 1868, Pacific Life provides a wide range of life insurance products, annuities, and mutual funds, and offers a variety of investment products and services...

More Information about "Pacific EcoSolutions, Inc" on BioPortfolio

We have published hundreds of Pacific EcoSolutions, Inc news stories on BioPortfolio along with dozens of Pacific EcoSolutions, Inc Clinical Trials and PubMed Articles about Pacific EcoSolutions, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pacific EcoSolutions, Inc Companies in our database. You can also find out about relevant Pacific EcoSolutions, Inc Drugs and Medications on this site too.

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record